The drug industry is lobbying for potential tariffs to be implemented gradually instead of immediately being imposed at a 25% ...

Vanguard Health Care Fund has assets of $40.5 billion but has been ailing in recent years. With a new manager in charge, what ...

LONDON/COPENHAGEN (Reuters) -Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled ...

In a statement on its website, Eli Lilly and Company (LLY) said it has no affiliation with hims & hers (HIMS). It added, “Zepbound can be ...

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

The company has a looming opportunity to grab the booming GLP-1 agonist market by the horns.

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at reducing Lp(a). Whether that will translate to a cardioprotective benefit won’t be answered until Phase 3 tests read out.

In an exclusive interview with NBC News, President Donald Trump said there were methods that would allow him to seek a third term in the White House.

The PGIM Jennison Growth Fund rose 6.5%, slightly underperforming the Russell 1000 Growth Index for Q4 2024. Click here to ...

BEIJING - US pharmaceutical giant Pfizer's new research and development (R&D) center officially opened at BioPark in the ...